Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Employers Look to Telehealth Firms to Decrease the Costs of Weight-Loss Shots

As uptake of GLP-1 increases among the general public, American employers are looking to find cheaper ways of offering weight-loss medications.
Ozempic
As more people flock to GLP-1 drugs for weight loss, employers who cover them are suffering from sticker shock. (Shutterstock)

Telehealth companies Hims & Hers Health Inc., Noom Inc. and Sesame Inc. have lured individual customers with low-cost versions of popular weight-loss shots like Ozempic and Wegovy. Now, they’re going after employers, too, as the medications become an in-demand perk.

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

Further Reading

Wellness Wants in on the Ozempic Economy

From supplements to workout plans, the term GLP-1, the hormone associated with Ozempic, is popping up on a widespread range of new products as wellness brands join in on the weight loss drug boom.

In This Article

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.

Can Mikayla Nogueira Sell Fragrance, Too?

The beauty influencer is hoping her 20 million-strong following can cut through the category’s oversaturation with Only Sunshine, a tropical scent launched with indie brand Snif.


Ulta Beauty Joins TikTok Shop

Ulta Beauty becomes the first US specialty beauty retailer to launch on TikTok Shop, making the case for partnership rather than competition with the platform’s beauty e-commerce business.


view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.
VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON